Novo Nordisk's Rybelsus has become the first oral GLP-1 agonist to pick up a regulatory approval for cardiovascular risk reduction, after getting a green light from the EMA's human medicine committee.

Kendrick Lamar and Drake’s feud has become one of the most storied rap beefs in history, but their relationship wasn’t always so fraught with tension. Just one year later, however, cracks in their ...